Toward an Integrated Therapeutic Approach for Familial Hypercholesterolemia

Area of Science:

• Cardiovascular Genetics
• Metabolic Disorders
• Pharmacology

Background:

• Familial hypercholesterolemia (FH) is an inherited condition characterized by impaired low-density lipoprotein cholesterol (LDL-C) clearance.
• This leads to elevated LDL-C levels from birth, significantly increasing the risk of premature atherosclerosis and cardiovascular events.
• Genetic variations in LDLR, APOB, and PCSK9 are key contributors to FH pathogenesis.

Purpose of the Study:

• To review the adverse effects of conventional hypercholesterolemia treatments.
• To highlight the need for safe and effective therapeutic strategies for FH.
• To explore an integrated management approach for FH.

Main Methods:

• Literature review of pharmacological, microbiome-based, molecular, nanotechnology, surgical, nutraceutical, herbal, and lifestyle interventions.
• Analysis of adverse effects associated with existing treatments.
• Evaluation of yoga and physical fitness as adjunctive therapies.

Main Results:

• Conventional treatments for hypercholesterolemia can present adverse effects.
• An integrated approach combining pharmacological, molecular, and lifestyle interventions is a pragmatic solution for FH.
• Yoga and fitness therapies demonstrate positive impacts on lipid profiles as non-pharmacological options.

Conclusions:

• An integrated, multifaceted approach is essential for comprehensive FH management.
• This approach should consider genetic predispositions, socioeconomic factors, and individual patient needs.
• Holistic strategies, including yoga and fitness, offer valuable adjunctive benefits for FH patients.